Orthofix Medical Inc. (OFIX:NASDAQ) closed at $9.81 on October 23, 2026, down 1.80% on the day. The stock trades 42.3% below its 52-week high of $16.99 and 15.4% above its 52-week low of $8.50. Over the past year, it lost 38.6%. Orthofix Medical Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 23, 2025, OFIX closed higher on 120 days (48%). Its best day was July 6, 2026 (+16.40%) and its worst was August 5, 2026 (-14.59%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The company markets and distributes its products directly, as well as through independent distributors and independent sales representatives to hospitals, doctors, and other healthcare providers. Orthofix...
Find more stocks like OFIX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.